LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities...
Related Questions
What potential settlement amounts or legal outcomes could materially impact the company's valuation and earnings guidance?
Will this lawsuit trigger any regulatory reviews or credit rating actions that could influence investor confidence and financing costs?
How might the securities fraud lawsuit affect Hims & Hers' short-term stock volatility and trading volume?